Masimo Co. (MASI) Shares Sold by King Luther Capital Management Corp

King Luther Capital Management Corp lowered its position in Masimo Co. (NASDAQ:MASI) by 56.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,220 shares of the medical equipment provider’s stock after selling 5,450 shares during the quarter. King Luther Capital Management Corp’s holdings in Masimo were worth $365,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently modified their holdings of MASI. Great West Life Assurance Co. Can boosted its holdings in Masimo by 0.3% in the second quarter. Great West Life Assurance Co. Can now owns 26,913 shares of the medical equipment provider’s stock valued at $2,452,000 after acquiring an additional 88 shares during the last quarter. Daiwa Securities Group Inc. acquired a new position in Masimo in the second quarter valued at $219,000. World Asset Management Inc boosted its holdings in Masimo by 4.6% in the second quarter. World Asset Management Inc now owns 2,853 shares of the medical equipment provider’s stock valued at $260,000 after acquiring an additional 126 shares during the last quarter. Retirement Systems of Alabama boosted its holdings in Masimo by 48.8% in the second quarter. Retirement Systems of Alabama now owns 86,180 shares of the medical equipment provider’s stock valued at $7,858,000 after acquiring an additional 28,248 shares during the last quarter. Finally, Cigna Investments Inc. New acquired a new position in Masimo in the second quarter valued at $332,000. Hedge funds and other institutional investors own 83.74% of the company’s stock.

Masimo Co. (MASI) opened at $86.00 on Friday. Masimo Co. has a one year low of $63.71 and a one year high of $104.71. The company has a market capitalization of $4,443.71, a PE ratio of 32.95, a P/E/G ratio of 2.90 and a beta of 0.72.

Masimo (NASDAQ:MASI) last released its quarterly earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.53 by $0.17. Masimo had a return on equity of 22.17% and a net margin of 45.83%. The business had revenue of $193.69 million for the quarter, compared to analysts’ expectations of $189.01 million. During the same quarter in the previous year, the firm posted $0.52 earnings per share. The company’s revenue was up 15.6% compared to the same quarter last year. research analysts expect that Masimo Co. will post 2.95 earnings per share for the current fiscal year.

MASI has been the topic of a number of recent research reports. Stifel Nicolaus restated a “buy” rating and set a $108.00 price objective on shares of Masimo in a research note on Friday, November 3rd. Zacks Investment Research upgraded Masimo from a “hold” rating to a “buy” rating and set a $98.00 price objective on the stock in a research note on Thursday, November 2nd. BTIG Research upgraded Masimo from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Monday, August 14th. Finally, BidaskClub cut Masimo from a “hold” rating to a “sell” rating in a research note on Thursday. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company. Masimo currently has a consensus rating of “Hold” and a consensus target price of $97.17.

In related news, EVP Yongsam Lee sold 18,198 shares of the business’s stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $88.85, for a total value of $1,616,892.30. Following the completion of the sale, the executive vice president now directly owns 70,800 shares of the company’s stock, valued at $6,290,580. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Steven Barker sold 10,000 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $90.00, for a total value of $900,000.00. Following the completion of the sale, the director now directly owns 73,249 shares of the company’s stock, valued at $6,592,410. The disclosure for this sale can be found here. In the last quarter, insiders sold 53,074 shares of company stock worth $4,737,245. Insiders own 16.60% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.dispatchtribunal.com/2017/12/10/masimo-co-masi-shares-sold-by-king-luther-capital-management-corp.html.

Masimo Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply